| Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ... Oncogene 36 (16), 2286-2296, 2017 | 177 | 2017 |
| The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity S Ali, DA Heathcote, SHB Kroll, AS Jogalekar, B Scheiper, H Patel, ... Cancer research 69 (15), 6208-6215, 2009 | 171 | 2009 |
| The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer NC Wortham, E Ahamed, SM Nicol, RS Thomas, M Periyasamy, J Jiang, ... Oncogene 28 (46), 4053-4064, 2009 | 137 | 2009 |
| Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion VTM Nguyen, I Barozzi, M Faronato, Y Lombardo, JH Steel, N Patel, ... Nature communications 6 (1), 10044, 2015 | 135 | 2015 |
| miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts L Pellegrino, J Stebbing, VM Braga, AE Frampton, J Jacob, L Buluwela, ... Nucleic acids research 41 (10), 5400-5412, 2013 | 134 | 2013 |
| APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, A Harrod, ... Cell reports 13 (1), 108-121, 2015 | 128 | 2015 |
| ICEC0942, an orally bioavailable selective inhibitor of CDK7 for cancer treatment H Patel, M Periyasamy, GP Sava, A Bondke, BW Slafer, SHB Kroll, ... Molecular cancer therapeutics 17 (6), 1156-1166, 2018 | 110 | 2018 |
| A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor … DA Heathcote, H Patel, SHB Kroll, P Hazel, M Periyasamy, M Alikian, ... Journal of medicinal chemistry 53 (24), 8508-8522, 2010 | 107 | 2010 |
| Expression of CDK7, cyclin H, and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor–positive breast cancer H Patel, R Abduljabbar, CF Lai, M Periyasamy, A Harrod, C Gemma, ... Clinical Cancer Research 22 (23), 5929-5938, 2016 | 93 | 2016 |
| p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells M Periyasamy, AK Singh, C Gemma, C Kranjec, R Farzan, DA Leach, ... Nucleic acids research 45 (19), 11056-11069, 2017 | 86 | 2017 |
| The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells PTR Thiruchelvam, CF Lai, H Hua, RS Thomas, A Hurtado, W Hudson, ... Breast cancer research and treatment 127, 385-396, 2011 | 82 | 2011 |
| ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases J Lopez-Garcia, M Periyasamy, RS Thomas, M Christian, M Leao, P Jat, ... Nucleic acids research 34 (21), 6126-6136, 2006 | 73 | 2006 |
| Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo Y Lombardo, A Filipović, G Molyneux, M Periyasamy, G Giamas, Y Hu, ... Proceedings of the National Academy of Sciences 109 (41), 16558-16563, 2012 | 71 | 2012 |
| LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner HB Kramer, CF Lai, H Patel, M Periyasamy, ML Lin, SM Feller, ... Nucleic acids research 44 (2), 582-594, 2016 | 58 | 2016 |
| Low dose iron treatments induce a DNA damage response in human endothelial cells within minutes IG Mollet, D Patel, FS Govani, A Giess, K Paschalaki, M Periyasamy, ... PLoS One 11 (2), e0147990, 2016 | 56 | 2016 |
| Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth RS Tolhurst, RS Thomas, FJ Kyle, H Patel, M Periyasamy, A Photiou, ... Breast cancer research and treatment 128, 357-368, 2011 | 40 | 2011 |
| Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer ML Lin, H Patel, J Remenyi, CRS Banerji, CF Lai, M Periyasamy, ... Oncotarget 6 (25), 21685, 2015 | 30 | 2015 |
| Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer SC Baker, AS Mason, RG Slip, KT Skinner, A Macdonald, O Masood, ... Oncogene 41 (15), 2139-2151, 2022 | 28 | 2022 |
| Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB M Periyasamy, AK Singh, C Gemma, R Farzan, RC Allsopp, JA Shaw, ... Oncogene 40 (6), 1077-1090, 2021 | 25 | 2021 |
| Endonuclease FEN1 Coregulates ERα activity and provides a novel drug Interface in Tamoxifen-resistant breast Cancer KD Flach, M Periyasamy, A Jadhav, D Dorjsuren, JC Siefert, TE Hickey, ... Cancer research 80 (10), 1914-1926, 2020 | 23 | 2020 |
